**
Individuals in the UK suffering from hypermobility-related disorders, such as hypermobile Ehlers-Danlos syndrome (hEDS), are often subjected to alarming delays in diagnosis, with some waiting as long as 21 years. A comprehensive study conducted by the University of Edinburgh, involving over 2,000 participants, reveals that a significant lack of awareness among healthcare professionals contributes to these lengthy diagnostic journeys. The findings underscore the urgent need for improved recognition and treatment pathways for these complex conditions, which can severely impact patients’ quality of life.
The Scope of the Problem
Hypermobility spectrum disorders (HSD) encompass a range of conditions characterised by excessive joint flexibility, chronic pain, and a multitude of related symptoms including fatigue, neurological issues, and gastrointestinal disturbances. Despite the profound effects on daily living, awareness and understanding of these disorders among healthcare providers remain woefully inadequate.
The study’s participants reported a variety of symptoms, with 84% experiencing chronic pain, 74% suffering from dislocated joints, and 66% facing gastrointestinal issues. The mental health repercussions are equally concerning, with 71% reporting anxiety and 63% experiencing depression. These figures highlight the pervasive nature of the disorders, which extend far beyond joint issues and affect multiple bodily systems.
A Fragmented Healthcare System
The research illustrates the fragmented nature of healthcare for individuals with hEDS and HSD. Patients often require a referral from their general practitioner (GP) to see a specialist, which can lead to further delays. Once referred, patients may undergo genetic testing and consultations with various specialists, including rheumatologists and physiotherapists. However, the lack of a streamlined process often results in prolonged waiting times.
The study revealed that respondents in Wales faced the longest wait for diagnosis, averaging 21.7 years, followed closely by Northern Ireland at 21.1 years. In comparison, Scotland and England reported averages of 19.5 and 19 years, respectively. Notably, many respondents indicated that they had to travel long distances for a diagnosis, with over a third of Welsh and Northern Irish participants seeking care outside their home regions.
Calls for Change
In light of these findings, experts are calling for urgent reforms in the healthcare system to better support individuals with hypermobility disorders. Kathryn Berg, the trial and data manager at the University of Edinburgh’s Institute of Genetics and Cancer, emphasised the need for equitable and multidisciplinary care pathways tailored to the complex nature of these conditions.
In response to the identified gaps in care, the Welsh government has acknowledged the challenges faced by patients and is working on a “draft community health pathway” aimed at ensuring more consistent care and improved access to specialists. Meanwhile, a toolkit developed by the Royal College of General Practitioners, in collaboration with EDS Support UK, aims to enhance clinician awareness and management of these complex disorders.
Why it Matters
The staggering delays in diagnosing hypermobility spectrum disorders not only exacerbate physical suffering but also have far-reaching implications for mental health and overall well-being. As patients navigate a convoluted healthcare system, the need for greater awareness, improved diagnostic protocols, and comprehensive care pathways becomes increasingly apparent. Addressing these issues is essential for enhancing patient outcomes and ensuring that individuals with hEDS and HSD receive the recognition and care they deserve. The urgency of these reforms cannot be overstated, as they are fundamental to alleviating the burdens faced by countless individuals and their families.